Literature DB >> 7728521

Conserved expression of the opioid growth factor, [Met5]enkephalin, and the zeta (zeta) opioid receptor in vertebrate cornea.

I S Zagon1, J W Sassani, G Allison, P J McLaughlin.   

Abstract

In addition to neuromodulation, endogenous opioids serve as growth factors. The naturally occurring opioid peptide, [Met5]enkephalin, termed opioid growth factor (OGF), has been found to be a potent and tonic inhibitor of processes related to growth and renewal, particularly cell proliferation. OGF mediates its actions through the zeta (zeta) opioid receptor. In order to determine if OGF and/or the zeta receptor are present in human corneal epithelium, immunocytochemistry was utilized. Immunoreactivity with regard to OGF and to the zeta receptor could be detected in the cortical cytoplasm of both basal and suprabasal epithelial cells, but was not associated with the cell nucleus. Investigation of the ubiquity of OGF and zeta receptor in the vertebrate cornea showed that both elements are present in a wide variety of classes of the phylum Chordata, including mammalia, aves, reptilia, amphibia, and osteichthyes. These results suggest that an endogenous opioid system related to growth may have originated as early as 300 million years ago, and that the function of this system in cellular renewal and homeostasis is a requirement of the vertebrate corneal epithelium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728521     DOI: 10.1016/0006-8993(94)01314-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Sensory nerve regeneration after epithelium wounding in normal and diabetic cornea.

Authors:  Fu-Shin Yu; Jia Yin; Patrick Lee; Frank S Hwang; Mark McDermott
Journal:  Expert Rev Ophthalmol       Date:  2015-06-26

2.  Dysregulation of the OGF-OGFr pathway correlates with elevated serum OGF and ocular surface complications in the diabetic rat.

Authors:  Ian S Zagon; Joseph W Sassani; Indira Purushothaman; Patricia J McLaughlin
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-08

3.  Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits.

Authors:  I S Zagon; Joseph W Sassani; Melissa A Carroll; Patricia J McLaughlin
Journal:  Brain Res Bull       Date:  2009-10-21       Impact factor: 4.077

4.  The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation.

Authors:  Fan Cheng; Patricia J McLaughlin; Michael F Verderame; Ian S Zagon
Journal:  Mol Biol Cell       Date:  2008-10-15       Impact factor: 4.138

Review 5.  Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.

Authors:  Patricia J McLaughlin; Joseph W Sassani; Matthew S Klocek; Ian S Zagon
Journal:  Brain Res Bull       Date:  2009-08-14       Impact factor: 4.077

Review 6.  The Yin and Yang of the Opioid Growth Regulatory System: Focus on Diabetes-The Lorenz E. Zimmerman Tribute Lecture.

Authors:  Joseph W Sassani; Patricia J Mc Laughlin; Ian S Zagon
Journal:  J Diabetes Res       Date:  2016-09-14       Impact factor: 4.011

7.  Naltrexone as a Novel Therapeutic for Diabetic Corneal Complications.

Authors:  Patricia J McLaughlin; Joseph W Sassani; Ian S Zagon
Journal:  J Cell Immunol       Date:  2020

8.  Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.

Authors:  Patricia J McLaughlin; Ian S Zagon; Sunny S Park; Andrea Conway; Renee N Donahue; David Goldenberg
Journal:  BMC Cancer       Date:  2009-10-18       Impact factor: 4.430

Review 9.  Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin.

Authors:  Indira Purushothaman; Ian S Zagon; Joseph W Sassani; Patricia J McLaughlin
Journal:  Biochem Pharmacol       Date:  2021-07-26       Impact factor: 6.100

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.